We sought to evaluate the efficacy of abciximab as adjunctive therapy to routine infarct-related artery (IRA) stenting
Background: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However...
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analys...
Abciximab infusion and uncoated-stent implantation is a complementary treatment strategy to reduce m...
AbstractObjectivesWe sought to evaluate the efficacy of abciximab as adjunctive therapy to routine i...
OBJECTIVE: To assess the benefit resulting from the use of abciximab associated with primary angiopl...
BACKGROUND: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angiop...
Background-Trials of platelet glycoprotein IIb/IIIa inhibitors as adjuncts to primary percutaneous c...
BACKGROUND: Trials of platelet glycoprotein IIb/IIIa inhibitors as adjuncts to primary percutaneous ...
We used gated SPECT to evaluate the impact of abciximab on the efficacy of myocardial reperfusion in...
Objective- To assess the benefit resulting from the use of abciximab associated with primary angiopl...
Improvement of stent deployment techniques and advances in antiplatelet therapy have shown that sten...
Improvement of stent deployment techniques and advances in antiplatelet therapy have shown that sten...
Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarctio
AbstractObjectives. The purpose of this study was to compare the outcome of primary percutaneous tra...
Objective To evaluate the efficacy and safety of abciximab following acute myocardial infarction (AM...
Background: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However...
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analys...
Abciximab infusion and uncoated-stent implantation is a complementary treatment strategy to reduce m...
AbstractObjectivesWe sought to evaluate the efficacy of abciximab as adjunctive therapy to routine i...
OBJECTIVE: To assess the benefit resulting from the use of abciximab associated with primary angiopl...
BACKGROUND: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angiop...
Background-Trials of platelet glycoprotein IIb/IIIa inhibitors as adjuncts to primary percutaneous c...
BACKGROUND: Trials of platelet glycoprotein IIb/IIIa inhibitors as adjuncts to primary percutaneous ...
We used gated SPECT to evaluate the impact of abciximab on the efficacy of myocardial reperfusion in...
Objective- To assess the benefit resulting from the use of abciximab associated with primary angiopl...
Improvement of stent deployment techniques and advances in antiplatelet therapy have shown that sten...
Improvement of stent deployment techniques and advances in antiplatelet therapy have shown that sten...
Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarctio
AbstractObjectives. The purpose of this study was to compare the outcome of primary percutaneous tra...
Objective To evaluate the efficacy and safety of abciximab following acute myocardial infarction (AM...
Background: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However...
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analys...
Abciximab infusion and uncoated-stent implantation is a complementary treatment strategy to reduce m...
DOI
Add to ORKG